Clinical Trial Update: SyncAV Post-Market Trial [NA]

View source ↗

Summary

Post-market trial update for SyncAV pacing technology from Abbott Medical Devices; the congestive heart failure study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• SyncAV

Snippet

Sponsor: Abbott Medical Devices | Conditions: Congestive Heart Failure | NA | Status: ACTIVE_NOT_RECRUITING